Aurinia Pharmaceuticals Inc

(AUPH)

By |

Profile

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.

Contact Information

Website: www.auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: NSD
Employees: 16
NAICS: Pharmaceutical P
$ 2.81 ($ 0.04) (-1.40%)
Last Price 2.81 Change $ -0.04 Change % -1.40 Tick N/A
Bid 2.75 Bid Size 2,200.00 Ask 2.90 Ask Size 4,000.00
Open 2.85 High 2.90 Low 2.80 Prev Close 2.85
Last Trade Volume 328,136 52 Wk Hi 5.69 52 Wk Low 1.42
Market Cap 111.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,727,206.00 EPS (TTM) -0.44 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 9 10
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 8.67 8.67 7.67 8.67
Standard Deviation 1.53 1.53 1.15 1.53
Date of Most Recent Estimate 08/17/16 08/17/16 07/04/16 08/17/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1